PTCH1 and medulloblastoma: Interestingly, Gln-iPSCs with a heterozygous germline mutation of PTCH1 developed into medulloblastoma with a secondary somatic mutation, i.e. loss of heterozygosity (LOH), in PTCH1 in vivo.